ArticleOncology letters2024

Apatinib plus chemotherapy is associated with an improved tumor response, survival and tolerance compared with chemotherapy alone for advanced lung adenocarcinoma treatment.

Hua Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.